Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 11, 2025

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Yingmeng Ni1,2, Youchao Yu1,2, Ranran Dai1,2
1Department of Respiratory and Critical Care Medicine, Rui Jin Hospital, 66281Shanghai Jiao Tong University School of Medicine, Shanghai, China.
The diffusing capacity of the lung for carbon monoxide (DLCO) is a crucial measure for assessing chronic obstructive pulmonary disease (COPD) severity, exacerbation risk, and mortality. Incorporating DLCO into COPD assessments can enhance patient evaluation and prognosis prediction.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: